Altering the name of the Stem Cell Research Commission to be the Stem Cell and Biotechnologies Commercialization Commission; requiring the Commission to establish procedures and guidelines regarding research supporting a qualified technology; altering the name of the Maryland Stem Cell Research Fund to be the Maryland Stem Cell and Biotechnologies Commercialization Fund; altering the purpose of the Fund so as to support innovative biotechnology research and development that has the potential to create job growth; etc.